|
1
|
Bosch FX, Manos MM, Muñoz N, et al:
Prevalence of human papillomavirus DNA in cervical cancer: a
worldwide perspective. International biological study on cervical
cancer (IBSCC) study group. J Natl Cancer Inst. 87:796–802. 1995.
View Article : Google Scholar
|
|
2
|
Liu Y, Chen JJ, Gao Q, et al: Multiple
functions of human papillomavirus type 16 E6 contribute to the
immortalization of mammary epithelial cells. J Virol. 73:7297–7307.
1999.PubMed/NCBI
|
|
3
|
Lehoux M, D’Abramo CM and Archambault J:
Molecular mechanisms of human papillomavirus-induced
carcinogenesis. Public Health Genomics. 12:268–280. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Moody CA and Laimins LA: Human
papillomavirus oncoproteins: pathways to transformation. Nat Rev
Cancer. 10:550–560. 2010. View
Article : Google Scholar : PubMed/NCBI
|
|
5
|
Huibregtse JM, Scheffner M and Howley PM:
A cellular protein mediates association of p53 with the E6
oncoprotein of human papillomavirus types 16 or 18. EMBO J.
10:4129–4135. 1991.PubMed/NCBI
|
|
6
|
Huertas-Salgado A, Martín-Gámez DC, Moreno
P, et al: E6 molecular variants of human papillomavirus (HPV) type
16: an updated and unified criterion for clustering and
nomenclature. Virology. 410:201–215. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Ellis JR, Etherington I, Galloway D, et
al: Antibody responses to HPV16 virus-like particles in women with
cervical intraepithelial neoplasia infected with a variant HPV16.
Lancet. 34:1069–1070. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Zehbe J, Mytilineos I, Wikstrom R, et al:
Association between human papillomavirus 16 E6 variants and human
leukocyte antigen class I polymorphism in cervical cancer of
Swedish women. Hum Immunol. 64:538–542. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Andersson S, Alemi M, Rylander E, et al:
Uneven distribution of HPV 16 E6 prototype and variant (L83V)
oncoprotein in cervical neoplastic lesions. Br J Cancer.
83:307–310. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Zehbe I, Wilander E, Delius H, et al:
Human papillomavirus 16 E6 variants are more prevalent in invasive
cervical carcinoma than the prototype. Cancer Res. 58:829–833.
1998.PubMed/NCBI
|
|
11
|
Stoppler MC, Ching K, Stoppler H, et al:
Natural variants of the human papillomavirus type 16 E6 protein
differ in their abilities to alter keratinocyte differentiation and
to induce p53 degradation. J Virol. 70:6987–6993. 1996.PubMed/NCBI
|
|
12
|
Chakrabarti O, Veeraraghavalu K,
Tergaonkar V, et al: Human papillomavirus type 16 E6 amino acid 83
variants enhance E6-mediated MAPK signaling and differentially
regulate tumorigenesis by notch signaling and oncogenic Ras. J
Virol. 78:5934–5945. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Cai HB, Chen CC and Ding XH: Human
papillomavirus type 16 E6 gene variations in Chinese population.
Eur J Surg Oncol. 36:160–163. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Matsumoto K, Yoshikawa H, Nakagawa S, et
al: Enhanced oncogenicity of human papillomvairus type 16 (HPV16)
variants in Japanese population. Cancer Lett. 56:159–165. 2000.
View Article : Google Scholar
|
|
15
|
Kang S, Jeon YT, Kim JW, et al:
Polymorphism in the E6 gene of human papillomavirus type 16 in the
cervical tissues of Korean women. Int J Gynecol Cancer. 15:107–112.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Jang M, Rhee JE, Jang DH and Kim SS: Gene
expression profiles are altered in human papillomavirus-16 E6
D25E-expressing cell lines. Virol J. 8:4532011. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Thomas M, Pim D and Banks L: The role of
the E6-p53 interaction in the molecular pathogenesis of HPV.
Oncogene. 18:7690–7700. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Kessis TD, Slebos RJ, Nelson WG, et al:
Human papillomavirus 16 E6 expression disrupts the p53-mediated
cellular response to DNA damage. Proc Natl Acad Sci USA.
90:3988–3992. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Bernard HU, Calleja-Macias IE and Dunn ST:
Genome variation of human papillomavirus types: phylogenetic and
medical implications. Int J Cancer. 118:1071–1076. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Hildesheim A and Wang SS: Host and viral
genetics and risk of cervical cancer: a review. Virus Res.
89:229–240. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Zehbe I, Voglino G, Delius H, et al: Risk
of cervical cancer and geographical variations of human
papillomavirus 16 E6 polymorphisms. Lancet. 352:1441–1442. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Kämmer C, Tommasino M, Syrjänen S, et al:
Variants of the long control region and the E6 oncogene in European
human papillomavirus type 16 isolates: implications for cervical
disease. Br J Cancer. 86:269–273. 2002.PubMed/NCBI
|
|
23
|
Grodzki M, Besson G, Clavel C, et al:
Increased risk for cervical disease progression of French women
infected with the human papillomavirus type 16 E6-350G variant.
Cancer Epidemiol Biomarkers Prev. 15:820–822. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
McLaughlin-Drubin ME and Munger K:
Oncogenic activities of human papillomaviruses. Virus Res.
143:195–208. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Howie HL, Katzenellenbogen RA and Galloway
DA: Papillomavirus E6 proteins. Virology. 384:324–334. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Scheffner M, Werness BA, Huibregtse JM,
Levine AJ and Howley PM: The E6 oncoprotein encoded by human
papillomavirus types 16 and 18 promotes the degradation of p53.
Cell. 63:1129–1136. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Rowland BD and Peeper DS: KLF4, p21 and
context-dependent opposing forces in cancer. Nat Rev Cancer.
6:11–23. 2006. View
Article : Google Scholar : PubMed/NCBI
|
|
28
|
Munger K and Howley PM: Human
papillomavirus immortalization and transformation functions. Virus
Res. 89:213–228. 2002. View Article : Google Scholar : PubMed/NCBI
|
